OMNIAB, INC. (OABI) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $15.00K; Additional Paid in CapitalUSD $440.02M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-20.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $14.00K; Additional Paid in CapitalUSD $436.52M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $14.00K; Additional Paid in CapitalUSD $433.18M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $12.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $14.00K; Additional Paid in CapitalUSD $429.43M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $5.00K.
OMNIAB, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $15.00K | $440.02M | $-20.00K | $-179.75M | $260.27M | (m) | 3 month · $3.16M | (m) | (m) |
| 2026-03-31 | $0.00 | $14.00K | $436.52M | $-2.00K | $-173.89M | $262.65M | (m) | 3 month · $3.34M | (m) | (m) |
| 2025-12-31 | $0.00 | $14.00K | $433.18M | $12.00K | $-166.18M | $267.03M | (m) | 12 month · $15.82M | (m) | (m) |
| 2025-09-30 | $0.00 | $14.00K | $429.43M | $5.00K | $-152.00M | $277.44M | (m) | 3 month · $3.96M | (m) | (m) |
| 2025-06-30 | $0.00 | $12.00K | $397.53M | $-2.00K | $-135.47M | $262.06M | (m) | 3 month · $4.11M | (m) | (m) |
| 2025-03-31 | $0.00 | $12.00K | $393.10M | $8.00K | $-119.60M | $273.52M | 3 month · $71.00K | 3 month · $4.14M | (m) | (m) |
| 2024-12-31 | $0.00 | $12.00K | $388.98M | $27.00K | $-101.40M | $287.62M | (m) | 12 month · $21.50M | (m) | (m) |
| 2024-09-30 | $0.00 | $12.00K | $380.00M | $49.00K | $-88.33M | $291.73M | (m) | 3 month · $5.30M | (m) | (m) |
| 2024-06-30 | $0.00 | $12.00K | $366.15M | $-25.00K | $-71.96M | $294.18M | (m) | 3 month · $5.38M | (m) | (m) |
| 2024-03-31 | $0.00 | $12.00K | $359.73M | $-17.00K | $-58.33M | $301.39M | (m) | 3 month · $5.70M | (m) | (m) |
| 2023-12-31 | $0.00 | $12.00K | $353.89M | $50.00K | $-39.37M | $314.58M | (m) | 12 month · $24.82M | (m) | (m) |
| 2023-09-30 | $0.00 | $12.00K | $349.90M | $-49.00K | $-25.31M | $324.55M | (m) | 3 month · $6.31M | (m) | (m) |
| 2023-06-30 | $0.00 | $12.00K | $343.42M | $-49.00K | $-9.58M | $333.81M | (m) | 3 month · $6.53M | (m) | (m) |
| 2023-03-31 | $0.00 | $12.00K | $335.63M | $7.00K | $5.15M | $340.80M | (m) | 3 month · $6.05M | (m) | (m) |
| 2022-12-31 | $0.00 | $12.00K | $330.10M | $9.00K | $11.25M | $341.37M | (m) | 12 month · $3.88M | (m) | (m) |
| 2022-11-01 | (m) | $12.00K | $325.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | $-13.87M | $232.71M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | $-14.34M | $226.94M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | $-12.36M | $224.92M | 3 month · $632.36K | (m) | (m) | (m) |
| 2022-01-01 | (m) | (m) | (m) | (m) | (m) | $-7.55M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $234.31M | 11 month · $632.36K | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | $-6.90M | $-6.90M | 8 month · $13.35M | (m) | 3 month · $12.31M | 3 month · $9.25M |
| 2021-08-12 | (m) | (m) | (m) | (m) | $-6.74M | $-6.74M | $632.36K | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $24.43K | (m) | $-9.97K | $15.03K | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $17.21K | (m) | (m) | (m) | (m) |
| 2021-02-05 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2021-02-04 | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | $235.54M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |